Amgen, Inc. (AMGN)
466.01
+5.28
(+1.15%)
USD |
NASDAQ |
Oct 30, 16:00
466.40
+0.39
(+0.08%)
After-Hours: 20:00
Amgen 30-Day Average Daily Volume : 2.742M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.742M |
| October 29, 2026 | 2.917M |
| October 28, 2026 | 2.925M |
| October 27, 2026 | 2.908M |
| October 26, 2026 | 2.937M |
| October 23, 2026 | 2.959M |
| October 22, 2026 | 2.966M |
| October 21, 2026 | 2.977M |
| October 20, 2026 | 2.987M |
| October 19, 2026 | 3.141M |
| October 16, 2026 | 3.107M |
| October 15, 2026 | 3.083M |
| October 14, 2026 | 3.005M |
| October 13, 2026 | 2.980M |
| October 12, 2026 | 2.981M |
| October 09, 2026 | 2.982M |
| October 08, 2026 | 2.956M |
| October 07, 2026 | 2.953M |
| October 06, 2026 | 2.948M |
| October 05, 2026 | 2.962M |
| October 02, 2026 | 2.929M |
| October 01, 2026 | 2.909M |
| September 30, 2026 | 2.911M |
| September 29, 2026 | 2.893M |
| September 28, 2026 | 2.864M |
| Date | Value |
|---|---|
| September 25, 2026 | 2.835M |
| September 24, 2026 | 2.854M |
| September 23, 2026 | 2.838M |
| September 22, 2026 | 2.812M |
| September 21, 2026 | 2.753M |
| September 18, 2026 | 2.718M |
| September 17, 2026 | 2.520M |
| September 16, 2026 | 2.604M |
| September 15, 2026 | 2.645M |
| September 14, 2026 | 2.673M |
| September 11, 2026 | 2.647M |
| September 10, 2026 | 2.672M |
| September 09, 2026 | 2.658M |
| September 08, 2026 | 2.674M |
| September 04, 2026 | 2.543M |
| September 03, 2026 | 2.571M |
| September 02, 2026 | 2.607M |
| September 01, 2026 | 2.583M |
| August 31, 2026 | 2.600M |
| August 28, 2026 | 2.586M |
| August 27, 2026 | 2.623M |
| August 26, 2026 | 2.643M |
| August 25, 2026 | 2.628M |
| August 24, 2026 | 2.620M |
| August 21, 2026 | 2.607M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 5.928M |
| Regeneron Pharmaceuticals, Inc. | 753586.4 |
| AbbVie, Inc. | 4.796M |
| Biogen, Inc. | 1.299M |
| Vertex Pharmaceuticals, Inc. | 1.263M |